Peter Shorett Will Lead Beth Israel Lahey Health
The current executive vice president and COO will take over as president and CEO in January 2027.
Updated on Oct. 9, 2026 in People
Live Poll
Do you trust internal promotions more than outside hires to lead your local hospital system?
Beth Israel Lahey Health has selected Peter Shorett to succeed outgoing CEO Kevin Tabb. Shorett, who has served as senior executive vice president and COO since 2019, will officially begin his new role in January 2027.
Why it matters
The leadership transition marks a significant change for the major health system as it seeks to continue integrating complex clinical services. Shorett is tasked with overseeing collaborative efforts, including the partnership with Dana-Farber for cancer care.
Beth Israel Lahey Health currently supports a workforce of 39,000 employees and provides care for 2.1 million patients across its network. The system has operated since its formation in 2019.
The players
Peter Shorett
He is the current senior executive vice president and COO of Beth Israel Lahey Health and a former senior partner at Chartis.
Kevin Tabb
He is the outgoing CEO of Beth Israel Lahey Health who announced his intent to step down in March 2026.
Beth Israel Lahey Health
This is a large health system serving Eastern Massachusetts and Southern New Hampshire.
The details
The board selected Peter Shorett following a national search to lead the system after Kevin Tabb steps down. Shorett will specifically focus on integrating cancer care services between Beth Israel Lahey Health and Dana-Farber in the Longwood Medical Area.
Timeline
The health system was formed in 2019, the same year Peter Shorett joined the organization.
Kevin Tabb announced his plan to step down in March 2026.
Peter Shorett begins his tenure as president and CEO in January 2027.
Market Landscape
The leadership change at Beth Israel Lahey Health follows a pattern of consolidation among large regional health networks aiming to streamline specialized services. This move positions the system to maintain its competitive standing against other major providers in the state through clinical partnerships like the Dana-Farber integration.
Patients across the network should expect continued operations as the transition occurs over the coming months. The leadership shift focuses on long-term clinical integration projects that aim to influence future cancer care delivery in the region.
The takeaway
Leadership transitions in large health systems are often indicators of shifting clinical priorities and long-term expansion goals. Stakeholders should monitor upcoming strategic announcements for impacts on service availability and network partnerships.
Further reading
For more on shifting roles in regional organizations, see People.
Live Poll
Do you trust internal promotions more than outside hires to lead your local hospital system?
